Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DocCheck AG is a prominent player in the European healthcare information services sector. Primarily based in Germany, the company specializes in providing a wide array of digital services tailored to the needs of healthcare professionals and medical experts. Key offerings from DocCheck AG include comprehensive online community platforms for healthcare professionals, medical supply e-commerce, and digital marketing services for medical and pharmaceutical companies. These platforms serve as vital hubs for the exchange of information, trends, and medical advancements, enhancing knowledge-sharing and collaboration within the medical industry. Additionally, DocCheck AG plays a significant role in the pharmaceutical marketing space by offering analytics and user insights, thereby aiding pharmaceutical companies in reaching targeted medical professionals efficiently. As a pivotal entity within the healthcare sector, DocCheck AG continues to leverage technology to support and streamline the daily operations of healthcare professionals and organizations across Europe.
11.82% operating margin is respectable but not wide. ROIC at 9.99%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue growth slowed to 0.7%, essentially flat. This is a business that needs a catalyst.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€54M
▲ +0.7% YoY
Net Income (TTM)
€5M
▲ +148.2% YoY
Op. Margin
11.82%
▲ +5.9pp YoY
ROIC
9.99%
▲ +6.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€7M
▲ +15.7% YoY
Op. Cash Flow (TTM)
€7M
▲ +12.8% YoY
Net Debt
-€16M
Net Cash Position
Cash & Equiv.
€21M
3Y CAGR: -14.5%
3Y CAGR: -2.0%
Continue Research